RETRACTION: The lncRNA LINC01194/miR-486-5p Axis Facilitates Malignancy in Non-Small Cell Lung Cancer via Regulating CDK4 (Retraction of Vol 13, Pg 3151, 2020)

被引：0
|
作者：
Xing, Z.
Zhang, Z.
Gao, Y.
机构：
来源：
ONCOTARGETS AND THERAPY | 2024年 / 17卷
关键词：
D O I：
10.2147/OTT.S465182
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [21] lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis
    Guo, Haiyan
    Lin, Shufang
    Gan, Zhenyong
    Xie, Jinglian
    Zhou, Jiaming
    Hu, Ming
    ONCOLOGY LETTERS, 2021, 22 (06)
  • [22] RETRACTION: lncRNA MRUL Suppressed Non-Small Cell Lung Cancer Cells Proliferation and Invasion by Targeting miR-17-5p/SRSF2 Axis
    Chen, Y.
    Shen, T.
    Ding, X.
    BIOMED RESEARCH INTERNATIONAL, 2024, 2024
  • [23] LncRNA FOXP4-AS promotes the progression of non-small cell lung cancer by regulating the miR-3184-5p/EIF5A axis
    Li, Dingbiao
    Li, Zhenhua
    Wang YanFei
    Ying Wang
    Shi, Jianlin
    Chang Liu
    Qu, Laihao
    Deng, Shoujun
    Xiong, Dalin
    JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2022, 16 (04) : 335 - 345
  • [24] RETRACTION: Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA (Retraction of Vol 24, Pg 213, 2020)
    Yang, Y.
    Huang, X. -J.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (08) : 3148 - 3148
  • [25] RETRACTION: lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis (Retraction of Vol 13, Pg 4523, 2020)
    Wei, P.
    Yang, J.
    Zhang, D.
    Cui, M.
    Li, L.
    ONCOTARGETS AND THERAPY, 2022, 15 : 133 - 133
  • [26] RETRACTION: Downregulation of miR-218 by nicotine promotes cell proliferation through targeting CDK6 in non-small cell lung cancer (Retraction of Vol 120, Pg 18370, 2019)
    Liu, Zhen
    Lu, Cuiling
    Zhao, Guanren
    Han, Xue
    Dong, Kaisheng
    Wang, Chuanhai
    Guan, Jing-Zhi
    Wang, Zhongyuan
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2024, 125 (10)
  • [27] RETRACTION: GBP1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Wnt/β-catenin signaling pathway (Retraction of Vol 24, Pg 5465, 2020)
    Song, J.
    Wei, O. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7221 - 7221
  • [28] RETRACTION: Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A (Retraction of Vol 23, Pg 649, 2019)
    Bian, W. G.
    Zhou, X. N.
    Song, S.
    Chen, H. T.
    Shen, Y.
    Chen, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (21) : 6444 - 6444
  • [29] miR-31/QKI-5 axis facilitates cell cycle progression of non-small-cell lung cancer cells by interacting and regulating p21 and CDK4/6 expressions
    Zhu, Wangyu
    Yu, Yun
    Fang, Kexin
    Xiao, Sisi
    Ni, Lianli
    Yin, Changtian
    Huang, Xiangjie
    Wang, Xinchen
    Zhang, Yongkui
    Le, Han-Bo
    Cui, Ri
    CANCER MEDICINE, 2023, 12 (04): : 4590 - 4604
  • [30] RETRACTION: IL-33 Promotes the Growth of Non-Small Cell Lung Cancer Cells Through Regulating miR-128-3p/CDIP1 Signalling Pathway (vol 13, pg 2379, 2021) (Retraction of Vol 13, Pg 2379, 2021)
    Zhou, X.
    Feng, Y.
    Liu, S.
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 823 - 823
12345